New skin graft aims to heal stubborn bedsores
NCT ID NCT07158658
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a special skin graft called NeoThelium FT to see if it can heal chronic pressure ulcers (bedsores) in 10 adults. The goal is complete wound closure within 16 weeks. Participants must have stage 2 or 3 ulcers on the pelvis or leg, without infection, and meet other size and depth criteria.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRESSURE INJURY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
MedCentris of Bossier City
RECRUITINGBossier City, Louisiana, 71111, United States
-
MedCentris of Rayville
NOT_YET_RECRUITINGRayville, Louisiana, 71269, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simpler air mattress may prevent bedsores just as well — trial puts it to the test
- Blood gas clues could predict bedsores in intensive care
- Smartphone app aims to ease bed sore care for homebound patients
- Ear injury diagnosis showdown: which grading system wins?
- Easing the squeeze: new study aims to reduce ear pain in oxygen chambers
- New scale aims to boost nurse competency against bedsores